Posted on Dec 1, 2021

An FDA panel supports Merck COVID drug in mixed vote

PO1 William "Chip" Nagel

414

11

2

6

6

0

https://www.npr.org/sections/health-shots/2021/11/30/ [login to see] /an-fda-panel-supports-merck-covid-drug-in-mixed-vote
A panel of experts advising the Food and Drug Administration voted narrowly in favor of emergency use authorization of an antiviral pill from Merck and Ridgeback Biotherapeutics to treat COVID-19.

An FDA panel supports Merck COVID drug in mixed vote

Posted from npr.org

Posted in these groups: FDA Ems

Ems

Healthheart

Drug

Pharmaceuticals

Posted 3 y ago

Responses: 2

2

2

0

SrA John Monette

Posted 3 y ago

A 30% reduction in risk is far better than a 0% reduction.

(2)

Comment

(0)

2

2

0

Lt Col Charlie Brown

Posted 3 y ago

Interesting result...I guess we'll see how it goes as they test on patients.

(2)

Comment

(0)

Read This Next

RallyPoint Home